(PRWEB) June 13, 2012
Clapper Patti Schweizer & Mason have added an entire new section to their website to help patients and their families who are coping with a diagnosis of malignant mesothelioma. In addition to their Mesothelioma Treatment Section, patients can now also stay abreast of current clinical trials and research into finding even more effective ways to prevent, diagnose, and treat mesothelioma and asbestos related diseases.
Research into mesothelioma treatments continues both here in the United States and abroad. Malignant mesothelioma, sometimes referred to as asbestos cancer, is often not diagnosed until it has reached advanced stages and is more difficult to treat. The standard treatments for mesothelioma are surgery, chemotherapy and radiation therapy, but none of these have been very successful.
Clinical trials and medical investigative studies continue throughout the world to better understand this rare and aggressive type of cancer. Scientists are studying every aspect of this disease- from markers that could lead to earlier diagnosis to combining different mesothelioma chemotherapy drugs to more targeted, less invasive surgeries.
Clapper, Patti, Schweizer & Mason has created the Mesothelioma Treatment Research section on their website with summaries of the latest research into new and alternative mesothelioma treatments to help their clients and others suffering from this deadly disease.
Jack Clapper, founder of CPSM and leading attorney in the nation dedicated to representing clients in mesothelioma lawsuits in California, tells those who seek his advice: “There is a lot of information to wade through when you or a loved one is first diagnosed, and it can be quite overwhelming. We have been helping people diagnosed with mesothelioma for over 30 years, and in that time, we have seen a lot of progress in the types of treatments available. We hope that by providing summaries of recent research, clients – especially those newly diagnosed - will have an easier time choosing what treatment is best for their particular type of mesothelioma.”
A sampling of research posted includes:
Combined Immunotherapy and Chemotherapy Mesothelioma Treatment Improves Prognosis, discussing results from a recent clinical trial from an international group of scientists working with the Cancer Research Institute. The study showed that combining immunotherapy, a type of treatment that uses the body's own immune system to fight cancer, with chemotherapy greatly improved the prognosis of mesothelioma patients.
We posted similar results from another study conducted by Italian scientists that also showed combination, or multimodal, therapy for peritoneal mesothelioma leads to longer survival times: Multimodal Treatment for Peritoneal Mesothelioma Quadruples Life Expectancy.
Results from studies are released frequently, and those most pertinent to mesothelioma patients will be included in this new resource section. Clapper, Patti, Schweizer & Mason is committed to helping those who have been injured by asbestos to get not only the best legal representation but also access to the most current treatments available. To request a free brochure that includes essential medical and legal information or to speak directly with one of our expert mesothelioma attorneys, call 1-800-440-4262.
About Clapper, Patti, Schweizer & Mason
CPSM is a mesothelioma law firm based in California that has represented thousands of clients from all over the United States in asbestos lawsuits and bankruptcy claims. Unlike many other law firms, CPSM solely focuses on asbestos litigation, with a long record of winning millions of dollars in awards for their clients. If you or a loved one has been diagnosed, contact CPSM today to speak directly with an asbestos attorney who will fight for your rights until justice is served.